Literature DB >> 23542927

Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.

Hugo A Tejeda1, Danielle S Counotte, Eric Oh, Sammanda Ramamoorthy, Kristin N Schultz-Kuszak, Cristina M Bäckman, Vladmir Chefer, Patricio O'Donnell, Toni S Shippenberg.   

Abstract

Kappa-opioid receptors (KORs) are important for motivation and other medial prefrontal cortex (mPFC)-dependent behaviors. Although KORs are present in the mPFC, their role in regulating transmission in this brain region and their contribution to KOR-mediated aversion are not known. Using in vivo microdialysis in rats and mice, we demonstrate that intra-mPFC administration of the selective KOR agonist U69,593 decreased local dopamine (DA) overflow, while reverse dialysis of the KOR antagonist nor-Binaltorphimine (nor-BNI) enhanced mPFC DA overflow. Extracellular amino-acid levels were also affected by KORs, as U69,593 reduced glutamate and GABA levels driven by the glutamate reuptake blocker, l-trans-pyrrolidine-2,4-dicarboxylate. Whole-cell recordings from mPFC layer V pyramidal neurons revealed that U69,593 decreased the frequency, but not amplitude, of glutamatergic mini EPSPs. To determine whether KOR regulation of mPFC DA overflow was mediated by KOR on DA terminals, we utilized a Cre recombinase-driven mouse line lacking KOR in DA neurons. In these mice, basal DA release or uptake was unaltered relative to controls, but attenuation of mPFC DA overflow by local U69,593 was not observed, indicating KOR acts directly on mPFC DA terminals to locally inhibit DA levels. Conditioning procedures were then used to determine whether mPFC KOR signaling was necessary for KOR-mediated aversion. U69,593-mediated conditioned place aversion was blocked by intra-mPFC nor-BNI microinjection. These findings demonstrate that mPFC KORs negatively regulate DA and amino-acid neurotransmission, and are necessary for KOR-mediated aversion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542927      PMCID: PMC3717537          DOI: 10.1038/npp.2013.76

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  43 in total

1.  U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice.

Authors:  P M Wall; C Messier
Journal:  Brain Res       Date:  2000-02-21       Impact factor: 3.252

2.  Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex.

Authors:  Adena L Svingos; Eric E O Colago
Journal:  Brain Res       Date:  2002-08-16       Impact factor: 3.252

3.  Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms.

Authors:  Gregory O Hjelmstad; Howard L Fields
Journal:  J Neurophysiol       Date:  2003-05       Impact factor: 2.714

4.  Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell.

Authors:  G O Hjelmstad; H L Fields
Journal:  J Neurophysiol       Date:  2001-03       Impact factor: 2.714

5.  Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory.

Authors:  Philip M Wall; Claude Messier
Journal:  Psychopharmacology (Berl)       Date:  2002-01-31       Impact factor: 4.530

6.  Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.

Authors:  S L Walsh; E C Strain; M E Abreu; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2001-09       Impact factor: 4.530

7.  L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.

Authors:  S Sbrenna; M Marti; M Morari; G Calo; R Guerrini; L Beani; C Bianchi
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

8.  Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.

Authors:  Mark S Todtenkopf; Jacqueline F Marcus; Philip S Portoghese; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2004-01-16       Impact factor: 4.530

9.  Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Antonello Bonci; Howard L Fields
Journal:  J Neurosci       Date:  2003-11-05       Impact factor: 6.167

10.  Cocaine-induced Fos expression in rat striatum is blocked by chloral hydrate or urethane.

Authors:  J D Kreuter; B J Mattson; B Wang; Z-B You; B T Hope
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  56 in total

Review 1.  G Protein-coupled Receptor Biased Agonism.

Authors:  Sima Y Hodavance; Clarice Gareri; Rachel D Torok; Howard A Rockman
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

2.  Mephedrone alters basal ganglia and limbic dynorphin systems.

Authors:  Christopher L German; Mario E Alburges; Amanda J Hoonakker; Annette E Fleckenstein; Glen R Hanson
Journal:  Synapse       Date:  2014-09-08       Impact factor: 2.562

3.  A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference.

Authors:  Padmanabhan Mannangatti; Kamalakkannan NarasimhaNaidu; Mohamad Imad Damaj; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

4.  Fischer rats are more sensitive than Lewis rats to the suppressive effects of morphine and the aversive kappa-opioid agonist spiradoline.

Authors:  Christopher S Freet; Robert A Wheeler; Ellen Leuenberger; Nicole A S Mosblech; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2013-10       Impact factor: 1.912

5.  Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs.

Authors:  Hugo A Tejeda; Ashley N Hanks; Liam Scott; Carlos Mejias-Aponte; Zoë A Hughes; Patricio O'Donnell
Journal:  Neuropsychopharmacology       Date:  2015-05-14       Impact factor: 7.853

Review 6.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

Review 7.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 8.  Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.

Authors:  William A Carlezon; Andrew D Krystal
Journal:  Depress Anxiety       Date:  2016-10       Impact factor: 6.505

9.  Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.

Authors:  Chloe M Erikson; Gengze Wei; Brendan M Walker
Journal:  Neuropharmacology       Date:  2018-07-31       Impact factor: 5.250

10.  Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats.

Authors:  Sunil Sirohi; Brendan M Walker
Journal:  J Neurochem       Date:  2015-09-11       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.